Aldosterone: mechanisms of normal and impaired regulation and the possibility of their correction in arterial hypertension. Consensus of Russian Medical Society on Arterial Hypertension (RSH) experts
Open Access
- 31 July 2026
- journal article
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 98 (7) , 391-412
Abstract
In recent years, studies have been carried out that have expanded the understanding of the role of pathophysiological mechanisms underlying impaired regulation of aldosterone and activation of mineralocorticoid receptors in arterial hypertension. The aim of this consensus is to consider the association between aldosterone dysregulation and the development of cardiovascular complications, as well as to assess the effectivity and safety of novel nonsteroidal mineralocorticoid receptor antagonists, to expand the understanding of their potential in ensuring the prevention of target organ damage and cardiovascular complications in the treatment of patients with hypertension, to analyze the potential of a new class of drugs – aldosterone synthase inhibitors – in ensuring the suppression of genomic and non-genomic effects of aldosterone and their adverse effects in patients with hypertension, to assess the efficacy of drug therapy including nonsteroidal mineralocorticoid receptor antagonists and aldosterone synthase inhibitors in the category of patients at high cardiovascular risk – in hypertension due to primary hyperaldosteronism.Keywords
This publication has 199 references indexed in Scilit:
- Practical consensus for the treatment and follow-up of primary aldosteronism: a multidisciplinary consensus documentEndocrine, 2024
- Evaluation of Intra-Renal Stiffness in Patients with Primary AldosteronismHigh Blood Pressure & Cardiovascular Prevention, 2021
- Non-Genomic Effects of Aldosterone2019
- The Multifaceted Mineralocorticoid Receptor2014
- Converging Indications of Aldosterone Antagonists (Spironolactone and Eplerenone): A Narrative Review of Safety ProfilesCurrent Hypertension Reports, 2014
- Excess aldosterone-induced changes in insulin signaling molecules and glucose oxidation in gastrocnemius muscle of adult male ratMolecular and Cellular Biochemistry, 2012
- Somatostatin receptor expression in adrenocortical tumors and effect of a new somatostatin analog SOM230 on hormone secretion in vitro and in ex vivo adrenal cellsJournal of Endocrinological Investigation, 2010
- Characterization of Resistant HypertensionAssociation Between Resistant Hypertension, Aldosterone, and Persistent Intravascular Volume ExpansionArchives of internal medicine (1960), 2008
- Comparison of Target Organ Damage in Renovascular and Essential HypertensionAmerican Journal of Hypertension, 1996
- Inhibitory effect of somatostatin on the growth and steroidogenic capacity of rat adrenal zona glomerulosaThe Journal of Steroid Biochemistry and Molecular Biology, 1984